STRASBOURG, France (AP) -- A cloud is hanging over the upcoming free-trade talks between the European Union and the United States after France said it won't back any deal that threatens the country's prestigious film, radio or TV industries.
The stakes are high because any deal could have major implications for global trade and could serve as a model for future deals. Together, the U.S. and the EU make up nearly half the world economy and 30 percent of global trade.
The audiovisual sectors have traditionally been excluded from global free-trade agreements under what is known as the "cultural exception," which allows governments to subsidize and protect them. In general, free-trade agreements are supposed to limit or ban such support.
"France is asking for an exclusion from the negotiation of what it considers of course to be cultural products but which are also a mark of European identity," French Trade Minister Nicole Bricq said in an interview with The Associated Press.
Top 10 Performing Stocks To Invest In 2015: Berkshire Bancorp Inc.(BERK)
Berkshire Bancorp Inc. operates as the bank holding company for The Berkshire Bank that provides community banking services to businesses, professionals, and retail customers primarily in New York City metropolitan area and the Villages of Goshen and Harriman. The company offers various deposit products, including statement savings accounts, NOW accounts, money market deposits accounts, checking accounts, time deposits, and certificates of deposit. Its loan portfolio comprises commercial mortgage loans secured by office buildings, retail establishments, multi-family residential real estate, and other types of commercial property; commercial loans to businesses for inventory financing, working capital, machinery and equipment purchases, expansion, and other business purposes; and residential mortgage loans secured by first liens on one-to-four family owner-occupied or rental residential real estate, as well as residential single family construction, home equity, and short-t erm fixed-rate consumer loans. Berkshire Bancorp Inc. also offers title insurance agency services. The company operates seven deposit-taking offices in New York City; four deposit-taking offices in Orange and Sullivan Counties, New York; one deposit taking office in Ridgefield, New Jersey; and one deposit taking office in Teaneck, New Jersey. The company was founded in 1979 and is based in New York, New York.
Advisors' Opinion:- [By Tim Melvin]
One interesting bank that is seeing insider buying activity is Berkshire Bancorp (BERK). The company has recently switched from the Nasdaq to OTC markets, but that has not stopped director Moses Marx from consistently buying BERK stock. Berkshire does business in the already overbanked New York and New Jersey markets, and the stock is very cheap at just 82% of book value. Insiders won more than 60% of the bank, so investors are on the same side of the table as management.
Hot Diversified Bank Stocks To Invest In Right Now: Rvue Holdings Inc (RVUE)
rVue Holdings, Inc., incorporated on November 12, 2008, is an advertising technology company and operate rVue, a demand-side platform (DSP) for planning, buying and managing digital place-based networks and digital billboards and signage (DOOH) advertising. It provides media services, including an online, Internet based DSP that connects advertisers and/or advertising agencies with third party DOOH media or networks, that allows the advertiser to create a targeted advertising campaign and media plan, and negotiate that media plan simultaneously with all the third-party networks selected. The Company provides network services and receive fees under contract or on a monthly basis, from Accenture.
The Company's rVue DSP is accessible via the Internet. Through rVue, once an advertising campaign has been agreed to between the advertiser and the DOOH network owner, the DOOH networks receive the display advertising to be shown on their installed base of digital media displays. rVue allows programming and advertising to be customized for display in specific venues, at specific times, and for demographic targeting. It provides the tools for advertisers and advertising agencies to customize campaigns for details as specific as location, customer preference, product availability, current events and other needs. It provides Proof-of-Play analytics and the network statistics necessary to monitor advertising on the networks and assist in evaluating the performance or refinements required for an advertising campaign, in some cases real time. As of December 31, 2012, 182 networks, which consists approximately 770,000 screens and delivering over 250 million daily impressions representing 50 market areas accessible through rVue.
In connection with the Transaction, the Company acquired from Argo all of its assets related to the rVue business, which included all of the common stock of rVue, Inc. as well as software, contracts and technology. Such software and technology included the rVue DSP t! echnology and software as well as legacy rVue client and server software, which allows an end user to manage and operate a DOOH network. The client software is used to manage each screen or site and the server software is used to manage the client software. The Company�� services provide a digital advertising solution that streamlines the process of planning, buying and optimizing display advertising on DOOH display networks. rVue is designed to simplify the process of buying and selling digital display ads while connecting all the market players networks, advertisers, agencies, partners and developers from a unified platform to do business more efficiently and effectively.
Advisors' Opinion:- [By CRWE]
Today, RVUE remains (0.00%) +0.000 at $.14 thus far (ref. google finance Delayed: 11:58AM EDT August 28, 2013).
rVue Holdings, Inc. previously reported its financial results for the quarter ended March, 31 2013.
Summary Results for First Quarter of 2013: Total revenue was $137.5K for the first fiscal quarter of 2013; up slightly from $131.5K the prior year.
Core Revenue: This is the focus of our business and source of future growth. Core revenue for the quarter ended March 31, 2013 was $79.3K up sharply (+63K) over Q1 2012 when it was $16.3K. Non-Core Revenue: For the quarters ended March 31, 2013 and 2012 were $58.2K and $115.2K, respectively. As stated earlier, the decline was due to the end of a management relationship with Auto Nation. This downward trend in non-core revenue is expected to continue through 2013 as we focus more resources on core business efforts. In addition, the Mattress Firm merged with Mattress Giant and we respectfully agreed not to renew for 2013. - [By CRWE]
Today, RVUE has shed (-0.25%)�0.000 at $.199 with�5,000 shares in play thus far (ref. google finance Delayed: 9:39AM EDT July 17, 2013), but don�� let this get you down.
rVue Holdings, Inc. previously reported its financial results for the full year ended December 31, 2012.
Summary Results for the Full Year of 2012: Total revenue was $602,363 for fiscal 2012; down slightly from $643,483 in the prior year. Core Fees: This is the focus of our business and source of future growth. Core revenue for the years ended December 31, 2012 and 2011 were, $197,444 and $203,276, respectively.
Non-Core Fees: For the years ended December 31, 2012 and 2011 were $404,919 and $440,207, respectively. The decline was due to the end of a management relationship with Auto Nation. This trend will continue in 2013 as we focus more resources on core business efforts. In addition the Mattress Firm merged with Mattress Giant and we respectfully agree not to renew for 2013 (this represented approximately $230,000 in revenue).
Hot Diversified Bank Stocks To Invest In Right Now: Altisource Portfolio Solutions S.A.(ASPS)
Altisource Portfolio Solutions S.A., together with its subsidiaries, provides services related to real estate and mortgage portfolio management, asset recovery, and customer relationship management primarily in the United States. Its Mortgage Services segment offers mortgage portfolio management services to loan originators and loan servicers. This segment provides asset management services that primarily include property preservation, property inspection, real estate owned (REO) asset management, and REO brokerage; residential property valuation; closing and title services; default management services, such as non-legal back-office support for foreclosure, bankruptcy, and eviction attorneys, as well as foreclosure trustee services. The company?s Financial Services segment offers unsecured asset recovery management services, including post-charge-off consumer debt collection that comprise credit cards, auto loans, and second mortgages; and customer relationship management services, such as customer care and early stage collection. Its Technology Services segment provides integrated technological solutions for loan servicing, vendor management, and invoice presentment and payment; and IT infrastructure services, such as desktop management, application support, network management, telephony, data center management, disaster recovery, helpdesk, and infrastructure security. This segment offers REALSuite of applications consisting of REALServicing, an enterprise residential mortgage loan servicing platform; REALTrans, an electronic business-to-business exchange that automates and simplifies the ordering, tracking, and fulfilling of mortgage and other services; and REALRemit, an electronic invoicing and payment system. The company serves sub-prime servicers, utility companies, commercial banks, servicers, mortgage bankers, and financial service companies, as well as hedge funds. Altisource Portfolio Solutions S.A. was incorporated in 1999 and is b ased in Luxembourg.
Advisors' Opinion:- [By Seth Jayson]
There's no foolproof way to know the future for Altisource Portfolio Solutions (Nasdaq: ASPS ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
Hot Diversified Bank Stocks To Invest In Right Now: Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company�� ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (IEMs) are treated. The Company has identified and validated novel and druggable targets in both cancer and IEMs. The Company�� two advanced cancer programs are targeting mutations in the enzymes isocitrate dehydrogenase 1 and 2, referred to as IDH1 and IDH2. The Company�� drug candidates are selective for the mutated forms of IDH1 and IDH2 found in cancer cells versus the normal forms of IDH1 and IDH2 found in all other cells.
The Company focused on developing medicines to address IEMs, with a novel approach to these orphan diseases for which no effective or disease-modifying therapy is available. The Company has also de-validated and terminated numerous programs, including many that have been reported in scientific journals. In the Company�� IEM portfolio, it uses an equally rigorous set of validation techniques.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Sangamo Biosciences (NASDAQ: SGMO) shot up 16.32 percent to $22.81 announced the publication in the NEJM of the first-in-man study of genome editing using its ZFN technology. Shares of Agios Pharmaceuticals (NASDAQ: AGIO) got a boost, shooting up 27.72 percent to $40.41 after the company reported quarterly results. BJ's (NASDAQ: BJRI) was also up, gaining 21.04 percent to $33.48 after the company was upgraded toa Buy rating at Buckingham research. - [By Roberto Pedone]
Another stock that insiders are moving into here is Agios Pharmaceuticals (AGIO), which focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism in the U.S. Insiders are buying this stock into major strength, since shares are up big so far in 2014 by 79%.
Agios Pharmaceuticals has a market cap of $1.4 billion and an enterprise value of $1.5 billion. This stock trades at a premium valuation, with a price-to-sales of 53.91 and a price-to-book of 11.51. Its estimated growth rate for this year is 48.1%, and for next year it's pegged at 15%. This is a cash-rich company, since the total cash position on its balance sheet is $162.27 million and its total debt is zero.
A director just bought 2,300 shares, or about $100,000 worth of stock, at $43.98 per share.
From a technical perspective, AGIO is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been selling off after a failed breakout attempt for the last few weeks, with shares moving lower from its high of $50.37 to its intraday low of $42.15 a share. That move is quickly pushing shares of AGIO within range of tagging its 50-day moving average of $40.27 a share.
If you're bullish on AGIO, then I would look for long-biased trades as long as this stock is trending above its 50-day at $40.27 and then once it breaks out above some near-term overhead resistance at $45 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 419,691 shares. If that breakout starts soon, then AGIO will set up to re-test or possibly take out its next major overhead resistance level at its all-time high of $50.37 a share. Any high-volume move above that level will then give AGIO a chance to tag $55 to $60 a share.
- [By Lisa Levin]
Agios Pharmaceuticals (NASDAQ: AGIO) shares touched a new 52-week low of $18.83. Agios Pharmaceuticals' trailing-twelve-month profit margin is -102.87%.
- [By Jake L'Ecuyer]
Shares of Agios Pharmaceuticals (NASDAQ: AGIO) got a boost, shooting up 29.08 percent to $40.84 after the company reported quarterly results.
Stage Stores (NYSE: SSI) was also up, gaining 13.47 percent to $22.41 after the company reported Q4 results and announced the sale of its Steele's off-price division to a new retail unit of Hilco Global.
Hot Diversified Bank Stocks To Invest In Right Now: Intermolecular Inc (IMI)
Intermolecular, Inc. (Intermolecular), incorporated on June 16, 2004, is engaged in research and development and time-to-market for the semiconductor and clean-energy industries. The Company, through paid collaborative development programs (CDPs) with its customers, develops technology and intellectual property (IP) for its customers focused on advanced materials, processes, integration and device architectures. The Company provides its customers with technology through various fee arrangements and grants them rights to associated IP, primarily through royalty-bearing licenses. Through paid CDPs and its own development, the Company has established a portfolio of greater than 1,000 patents and patent applications. Its approach is broadly applicable to high-volume integrated device markets, which include the markets for semiconductors, flat glass coatings and glass-based devices, solar cells, light-emitting diodes (LEDs), flat-panel displays, advanced batteries and other energy efficiency applications.
As of December 31, 2012, the Company targets large, high-volume semiconductor and high-growth emerging clean energy markets, including DRAM, non-volatile memory (including flash memory and embedded memory), complex logic, flat glass coatings and glass-based devices, solar cells, LEDs and other energy efficiency applications. The Company�� customers include ATMI, Inc. (ATMI), Elpida Memory, Inc. (Elpida), First Solar. Inc. (First), GLOBALFOUNDRIES Singapore Pte. Ltd (GLOBALFOUNDRIES), Guardian Industries Corp. (Guardian), SanDisk Corporation (SanDisk), Taiwan Semiconductor Manufacturing Company (TSMC) and Toshiba Corporation (Toshiba). For the year ended December 31, 2012, the Company has received the majority of its revenue from customers in DRAM, flash memory, complex logic and energy-efficient applications in flat glass. The elements in HPC platform include Tempus HPC processing, automated characterization, and informatics and analysis software. Tempus HPC processing are used to process ! different experiments consisting of combinations of materials, processing parameters, sequencing and device structures. Automated characterization systems are used to characterize the substrates processed by its Tempus HPC processing tools. Informatics and analysis software are used to automate experiment generation, characterization, data analysis and reporting.
The Company�� HPC platform consists of its Tempus HPC processing tools, automated characterization and informatics and analysis software. The Company�� platform is purpose-built for Research and Development (R and D) using combinatorial process systems. Combinatorial processing is a methodology for discovery and development that employs parallel and other high-throughput experimentation, which allows R and D experimentation to be performed at speeds up to 100 times faster than traditional methods. The Company�� processing tools allows performing up to 192 experiments on a single substrate.
Advisors' Opinion:- [By Sofia Horta e Costa]
ARM Holdings Plc (ARM) lost 2.6 percent, leading European technology companies lower before it publishes half-year results next week. IMI Plc (IMI) gained 2 percent as Citigroup Inc. listed the engineering company among its most preferred stocks.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Technology shares gained about 0.68 percent in today's trading. Meanwhile, top gainers in the sector included Intermolecular (NASDAQ: IMI), up 38.3 percent, and Infinera (NASDAQ: INFN), up 9.4 percent. In trading on Monday, utilities shares were relative laggards, down on the day by about 0.68 percent. - [By Lisa Levin]
Intermolecular (NASDAQ: IMI) shares touched a new 52-week low of $4.84. Intermolecular shares have dropped 45.09% over the past 52 weeks, while the S&P 500 index has gained 26.39% in the same period.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Technology shares gained about 0.68 percent in today's trading. Meanwhile, top gainers in the sector included Intermolecular (NASDAQ: IMI), up 38.3 percent, and Infinera (NASDAQ: INFN), up 9.4 percent. In trading on Monday, utilities shares were relative laggards, down on the day by about 0.68 percent.
No comments:
Post a Comment